Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Another great day with an exclamation point $10000 BUY in the last seconds before the bell
Showing superb strength think I will park some more loot here for the dogged days of summer WEEEEEE
$LEOM on the RISE
This is so ripe & ready for news I am starting to salivate on my L2
Sure got thin on the ask side now WOW
Low float, good bid support, profits, cd's done, GOLDEN CROSS!
Should be a fun & fast ride
$AMPG 2015
Everyone at the edge of your seats ... Is my L2 broke? Nearly every MM has the standard 10000 hiding the actual's.. I feel blind and L2 seems useless atm here today
Judging by the big hits in the morning this is the dip to get more or add imo ...
must be an MM conference call going on now shhhhh
Not much time before a dime!
We are favored in the mix here and this is happening NOW! Long time coming as WERPO/SDE has been on the scene as a pioneer in the planning stages for this project since 2010.
In the face of adversity, how 'bout them Blackhawks!?! WEEEEEE mirroring PPCH, bound to make a big come back for a run to the big prize.
I agree with Jack and the overall sentiment here this week end that when this gets in to the teens and twenties, and with an up list imminent, a whole new class of investor will grace this board leaving the small time flippers in the sewers of the OTC and thus reducing the extreme pps swings.
Disclaimer: I am not opposed to playing the occasional POS for a fast buck or two
Indeed everyone has their own style and strategy, and in the OTC there is no lack of tickers for quickie day trades/momo plays, but ultimately PPCH will emerge in to the upper echelon.
Can't say I have not enjoyed the said volatility several times myself in the past 3 months, after all, at least to some extent you have to do what the market tells you to and might as well go with the flow IF that opportunity presents. Love/Hate shorts lol.
However, with PPCH and the promising outlook, I have always retained and built on a core position as I feel those days are truly numbered with the advances about to take place here in short order. All imo.
I agree it has not even yet been determined the ratio there is lots of time for another run from here could be sweet
For that matter it could also be cancelled after all the cheapies are loaded lol
Getting coverage from notable newswires that focus on alternative & clean energy, here are a couple:
PPCH is a 100% BUY across the board @ Barchart.com!
Don't see that too often
http://www.barchart.com/opinions/stocks/PPCH
Looks like 30's are the new 20's ALREADY!!! Another stellar day here
Lovn' $LEOM
HTE to participate in inaugural SeeThruEquity Conference to be held in Warsaw Poland June 12
http://www.gpwinfostrefa.pl/GPWIS2/pl/news/info/706203,hydrophi-technologies-europe-sa-hydrophi-technologies-europe-s-a-wezmie-udzial-w-konferencji-seethru
I am waiting for you at what point will you "remind me about this post"
Snake in the grass will probably be back after a wardrobe change with his other persona
pffffft! WEEEEEEEEEEEEE!!
Impossible to be wrong when you flip flop all over the map and cover all bases hey?
This is the first time application submitted by HTEurope ..
PR dated Oct 30/14 that they received preliminary approval
http://finance.yahoo.com/news/hydrophi-technologies-europe-receives-preliminary-140005471.html
Between this and other national funds they have applied for in Poland up to 75% of the initial project costs could be funded!
Wow! He had quite a storied and enduring career beginning with being 2nd overall draft pick by my home province Canucks!...much respect.
My claim to fame is I am a cousin to Ray Bourque ... when I was 10 in his rookie 79-80 year I got to see all the games when they came to play where we lived at the time in Edmonton .. still have the team autographed stick he presented to me in the B's dressing room after a practice!
Here is that news I have no idea what was "corrected"..multiple positive developments sounds good to me
Corrected Article - The Road To The Cure: 4 Biotech Stocks Advancing New Therapies In The Fight Against Cancer
Accesswire
1 hour ago
WINDSOR, ON / ACCESSWIRE / May 19, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves.
The development of new cancer treatments is always ongoing and investors should monitor for emerging ideas and stocks. Companies like Propanc (PPCH), Cerulean Pharma (NASDAQ:CERU), Peregrine Pharma (NASDAQ:PPHM), and Verastem (NASDAQ:VSTM) could all move higher as their treatments potentially pass clinical testing thresholds. If investors can identify a few potential winners early on in the development process, returns could be substantial. Out of these four mentioned companies we believe Propanc (PPCH) is the most overlooked and presents investors with greatest potential return on investment, here's why:
Propanc, while small, has had a steady stream of positive news over the past three months. For Propanc Health Group, the share price has increased by more than 3,200%+ as a result of these new developments. In April, the company was featured in the NY Times Sunday Magazine in its feature 'Health Essentials: Cancer Prevention and Treatment'. The article featured the company's CEO and Co-Founder James Nathanielsz's perspective on the new developments with the company's technology and plans to commercialize it.
Propanc is a developmental stage healthcare company that is primarily focused on developing cancer treatments for pancreatic and colorectal cancer. The company has created an anti-cancer formulation that controls spreading of tumors throughout the body. The formulation consists of proenzymes (inactive precursors to enzymes) designed to fight or prevent cancer when activated at the tumor site. There are various oral enzyme preparations to support cancer patients, but none are yet clinically proven. The company is presently completing animal trials and then will undertake human trials before its primary products are marketable in the United States. However, the company may seek to license its technology to a major Pharma or Biotech company once proof of concept in cancer patients
FURTHER DEVELOPMENTS AT PROPANC
In March, the company announced it had entered the second stage of its POP1 research program with the University of Jaen and University of Granada, Spain. The research program is investigating the anti-cancer effects as well as the cellular mechanisms of proenzymes in the treatment of cancer. The study could help identify additional drugs beyond its core product, PRP. The company also has a joint research partnership with Bath University. It filed a joint patent with Bath University where it received the commercial rights. The team put together by Dr. Macarena Peran has pulled together these research institutions to continue to collaborate with the goal of finding additional compounds that complement existing cancer treatments.
Earlier this month the company reported that its first set of results were in from animal studies. The studies showed no adverse signs from using PRP at higher doses in mice when administered by intravenous (I.V) injection. The dose is more than double the human equivalent administered to late stage cancer patients for compassionate use by Dr Julian Kenyon (Propanc's Co-Founder and Chief Scientific Officer). This is a key step in more widespread studies. PRP was administered in the study by I.V. injection to ensure 100% was transferred to the bloodstream. Previously, it was administered via suppository where it likely has a much lower, uncertain absorption rate in the blood, but where outpatients could receive their once daily treatment at home for compassionate use.
All this supports the drugs' move towards human trials with an I.V. injection formulation. For shareholders and the company, this is positive news. It continues to advance PRP towards human trials. At each step, positive results could drive the stock higher as the likelihood of the future revenue stream improves.
REPAYMENT OF CONVERTIBLE DEBT, POSITIVE FOR SHAREHOLDERS
Propanc announced it had repaid convertible debt of $100,236.50 to KBM Worldwide, Inc. It is also looking to repay any other debts due beyond 90 days. This will minimize shareholder dilutions and is a positive sign from management. It indicated that management is positive about its current and future cash position.
STUDY OF PRP EFFECTS ON CANCER STEM CELLS
In this chain of positive announcements, Propanc along with its partner, University of Jaen, announced that it will study the effects of PRP on cancer stem cells. In prior studies, PRP induced differentiation of tumor cells, and it is testing the hypothesis that the formulation will induce differentiation on cancer stem cells as well. Cancer stem cells remain in a latent state and are not killed by radiation or chemotherapy. While other cancer cells may have been completely eliminated, the presence of these cancer stem cells can cause a relapse and metastasis.
OTHERS TARGETING CANCER TREATMENTS
A treatment that can impact these stem cells is in high demand. Verastem (NASDAQ:VSTM) is another company that focuses on this part of the market. It is developing small molecule drugs that target cancer stem cells. It has treatments that are currently in clinical trials that investors should also follow for new developments.
Cerulean Pharma (NASDAQ:CERU) is another company that is in the clinical stages of testing treatments. Like Verastem and Propanc, it is working in the field of oncology but also in the treatment of other diseases. The company develops nano pharmaceutical product candidates and has products in Phase I and Phase II clinical trials.
Peregrine Pharma (NASDAQ:PPHM) is another company investors should follow that is developing treatments for cancer. It is seeking to use monoclonal antibodies for the treatment and diagnosis of cancer. Its leading immunotherapy product, bavituximab, is in the late stages of clinical trials.
All of these companies, Propanc (PPCH), Cerulean Pharma (NASDAQ:CERU), Peregrine Pharma (NASDAQ:PPHM), and Verastem (NASDAQ:VSTM) are seeking to develop cancer treatments. Each company is working through various stages of clinical trials and as the trials advance, the share prices could follow. In addition to these positive results, shareholders could find earlier than expected payouts; large pharmaceutical companies are constantly acquiring promising new treatments and the companies that develop them. THIS COULD ALSO ACT AS A CATALYST TO MOVE THE SHARES OF THESE STOCKS HIGHER.
The Wealthy Biotech Trader is always researching new trade ideas which have the makings for large market moves. Traders are urged to follow our parent outlet, The Wealthy Venture Capitalist on social media (see below) to stay apprised. We are an anti-email media outlet, and as such will only be releasing our reports/ updates/ news through Twitter and Facebook as well as newswire.
GET BREAKING NEWS FROM US:
Follow us on Twitter: @Wealthy_VC
Like us on Facebook: www.facebook.com/WealthyVC
Email: Info@WealthyVentureCapitalist.com
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The Wealthy Biotech Trader and its employees are not a Registered Investment Advisors, Broker Dealers or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The Wealthy Biotech Trader encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and The Wealthy Biotech Trader makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor' in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security's previous day closing price and the high of day price during our promotional coverage.
The Wealthy Biotech Trader's parent company is and will be compensated roughly $5,000 per month by Propanc Health Group. The Wealthy Biotech Trader's controlling parent company has also been compensated $60,000 by Propanc Health Group in the form of a convertible note and readers should understand that they will convert this note into common shares sell them into the market as soon as the statutory 144 hold period has lapsed.
Readers must visit our website at www.wealthyventurecapitalist.com in order to view our entire disclaimer which covers most of the risks, biases and liability releases to have a full understanding after reading this article.
SOURCE: The Wealthy Biotech Trader
http://finance.yahoo.com/news/corrected-article-road-cure-4-210000610.html
Nothing wrong with a holding pattern and pretty typical historically before the next series of white candles
There is no denying this stock goes way outside just ihubbers looking for a quickie and both fundamentally and technically has more overwhelmingly good catalysts in play and on the way!... not stopping here.
Low volume just indicative of everyone wanting to find bottom and waiting to see how low Rake can go.
My apologies I should not have jumped to that conclusion. I was also answering tongue in cheek but it is hard to decipher my dry sense of humor on here lol
Blackhawks & PPCH both on the rebound in that order!!
Go BH & PPCH
Wait... you want me to answer the question you asked Rake? Being the mayor does not give you a pass to be pretentious .. assumed you were a mod .. .. just find it odd certain posters here get free reign spewing same message like a broken record
That is all
For a low volume manipulated day we actually saw some nice sized ASK slaps hit the tape .. GOOD DAY!
You are getting waaayy too far ahead of yourself again...There is nothing definitive in anything you say this is all speculation and conjecture from one goofball ..much like when you were pumping the polar opposite 4 short days ago
Most who flip flop so quickly and play Hyde to their Jeckyl at least use one of their different alias's lol
You are a walking contradiction with zero credibility and look extremely foolish on your attack at this point
It is obvious you have an agenda ...who would invest this kind of time in your rambling drivel over and over same message?
As a matter of fact you stated yesterday was your last post ..and on that merit alone no one believes the boy who cried 'wolf'
Shooo fly
A new financing initiative that seems tailor made for WERPO in China
China has become Israel's third largest trading partner @ $11 Billion!
That's twice now in the past week we got a small taste at opening of how quickly this can march up ..
Depending how strong the hands are that are accumulating all these cheapies this should rocket easily and faster back to 3's when the time comes
All the right ingredients here just add NEWS
So far just one seller who chose not to wait ... If it remains stable here i think there is a good chance we close green
Most of us here will
Hold The LINE
Take a look again at this statement from today's news there is no 'dumping' coming from the company
Ya so I sMeeLL ... guess we are not done feeding somebody down here
Call me crazy but I will take the .50 he entered initially as a clue where this will be going before the end of this year.
Nice jump! Bmak parked @ .50! I look forward to getting there
Hold the LINE on M LINE
Nice little tidbits in today's announcement
This guy is all over the map = FAKEMAN ..of course he believes he just blew his load last week and wants back in
Why else would he go bi-polar on us every other week?
Can't remember any other legit ticker on the OTC that had as much going for it in the purest form of that old cliche "ALL THE STARS ARE ALIGNED"
A lot of white noise on this board but to me the facts are overwhelmingly clear as day as to why the pps will appreciate and never come back to these levels.
-Further positive trial results expected to be announced anytime.
-Low O/S and M/C and especially relative to peers in the hottest and most promising market segment across all exchanges.
-Retired convertible debt and stated intent to retire more halting any foreseeable significant dilution
-Maxim retained for up list in the near future and will acquire further anti-dilutive financing
-Ramped up exposure and awareness leading in to SeeThruEquity presentation in 10 day countdown
-GOLDEN CROSS looking sweet and tightening bollies again (mirroring last run to .10 except this run going beyond)
-Panicked sellers last week are now buyers aiding in quickly forming next higher support .. add to that short positions WEEEEEEEEE
The volatility here used to be loads of fun but at this moment and as of late with calmed out lower volume the next leg to well above .10 is upon us .. my free cash is going all in... after that I may even free up more ;) GLTA
$PPCH
I am wondering if you sit beside Rake in the war room so he can pull your puppet strings? Or is your face on the back of his head?
Dang it he dropped his pants again! Still wonder if it is inevitable we will see NITE fill that 3 Milly at some point .. no interference from me today on my way to work ... if I am not watching maybe news will come
Love it! That's where this will be in short order ...I noticed he actually parked there yesterday afternoon ..possibly why some buyers on the sidelines pulled the trigger?
With the large bids all day I had a good feeling we would finish green again today but WOW great day! This should be the turn.
$HPTG
BMAK has left the building ..flippers get out of your own way lol
Follow the money! Sub-penny here is GOLD .. I too had the majority of my position under a penny last run ..not quite so this time..yet lol ..Look at NITE now 3 Milly bid .. do you think we are prolonging the agony to get in the way?
Good plan I am running a little interference here too
To put an exclamation point on your lack of judgement & credibility!! At least HPTG is a verifiable going concern unlike the list of no bid, A/S increasing POS's where you are currently "invested" and waiting for a miracle
$HPTG will turn on a dime with all the further PO's coming this year
Cream rises to the top... this team will eventually prevail
Most read is way more important than the 'break out board' far and away imo .. but I agree this particular stock does indeed also have a much further reach than i-hubbers
Enjoying the low volume stair steps this week ..much easier on the nerves at this juncture :)
HAHAHACQUISITIONS! perhaps I will retire with him HAHAHAHA GOOD TIMES
$MLHC